Latest News about SNY
Recent news which mentions SNY
From Benzinga
From Benzinga
Europe Approves Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6-11 Years With Type 2 Inflammation
April 07, 2022
From Benzinga
From Benzinga
2 Drugmakers Set for Explosive Revenue This Decade
April 03, 2022
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Why Did Truist Lower IGM Biosciences' Price Target?
March 30, 2022
From Benzinga
From Benzinga
53 Biggest Movers From Yesterday
March 30, 2022
From Benzinga
Why Is IGM Biosciences (IGMS) Stock Up Today?
March 29, 2022
From InvestorPlace
From Benzinga
From Benzinga
From Benzinga
36 Stocks Moving In Tuesday's Mid-Day Session
March 29, 2022
From Benzinga
Why IGM Biosciences Stock Rocketed Higher Today
March 29, 2022
From Motley Fool
From Benzinga
These 2 Stocks Are Up 20%-Plus in Tuesday's Premarket
March 29, 2022
From Motley Fool
From Benzinga
From Benzinga
20 Stocks Moving in Tuesday's Pre-Market Session
March 29, 2022
From Benzinga
From Benzinga
Regeneron-Sanofi's Dupixent Significantly Improved Signs, Symptoms In Chronic Itchy Skin Disease
March 28, 2022
From Benzinga
Are These 2 Rivals Beating Pfizer and Moderna?
March 28, 2022
From Motley Fool
1 Green Flag for Take-Two Interactive, and 1 Red Flag
March 26, 2022
From Motley Fool
From Motley Fool
Why Most Kids Did Not Suffer Badly Due To COVID-19 Infection? Scientists Look To Solve Mystery: CNBC
March 24, 2022
From Benzinga
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
March 22, 2022
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
